Erck Stanley C's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Sep 5, 2024
- Accession no.
- 0001415889-24-022941
- Filed
- Sep 5, 2024, 5:10 PM ET
- Trade date
- Sep 3-4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $191.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Erck Stanley CCIK 0001342826 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseAcquired | +17,922 | $0.04 | +$716.88 | 287,040 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −17,922 | $4.10 | −$73,480.2 | 269,118 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseAcquired | +29,767 | $0.04 | +$1,190.68 | 298,885 | Direct | |
| Sep 4, 2024 | Common Stock | SSaleDisposed | −29,767 | $3.97 | −$118,174.99 | 269,118 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseDisposed | −17,922 | $0.00 | $0 | 125,145 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseDisposed | −29,767 | $0.00 | $0 | 95,378 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.